Bridging the Gap for Ovarian Cancer Treatments Grants

Apply

Research priorities

Every year in Canada, almost 3,100 women are diagnosed with ovarian cancer. This disease actually manifests in several forms, each responding differently to treatments, which are not yet all sufficiently effective or adapted.

The Cancer Research Society and Ovarian Cancer Canada are proud to jointly announce an investment of $1.2 million to fund 2 clinical/translational research projects that will help improve precision oncology in the field of ovarian cancer.

*Treatments that can benefit women diagnosed with less common types of ovarian cancer (e.g. endometrioid, clear cell, low-grade serous, mucinous or non-epithelial) are encouraged.

Program information

Eligibility

The principal investigator and co-applicants must hold a research position at a Canadian institution and be able to hold research funds at their institution.

Budget

Each grant is limited to a maximum of $600,000 over a 3-year period.

Application process

A letter of intent is required for all applications. Selected applicants will be invited to submit a full application, which will be evaluated by a peer review committee.

UNITED AGAINST OVARIAN CANCER

By consolidating our efforts through exceptional partnerships, such as this one with our valued partner Ovarian Cancer Canada, we strive to make every donation a powerful catalyst for cancer research. This collaboration significantly amplifies our global impact in outsmarting ovarian cancer.